Seres Therapeutics Inc (MCRB) EPS is poised to hit -0.08 next quarter: How Investors Can Make It Count the Most?
Seres Therapeutics Inc (NASDAQ: MCRB) established initial surge of 4.73% at $0.82, before settling in for the price of $0.78 at the close. Taking a